Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Fernandes

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Journal of Visualized Experiments : Jove|May 21, 2015
Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applicationsJennifer M Vojtech, Juliana Cano-Mejia, Matthieu F Dumont, et al.
Nanomaterials (Basel, Switzerland)|August 12, 2022
Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for GlioblastomaNicole F Bonan, Debbie K Ledezma, Matthew A Tovar, et al.
Nanomedicine (London, England)|July 9, 2016
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapyRachel A Burga, Shabnum Patel, Catherine M Bollard, et al.
Translational Oncology|July 12, 2020
CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastomaJuliana Cano-Mejia, Anshi Shukla, Debbie K Ledezma, et al.
Biomaterials Science|February 22, 2019
Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastomaJuliana Cano-Mejia, Michelle L Bookstaver, Elizabeth E Sweeney, et al.
Cytotherapy|July 17, 2016
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cellsRachel A Burga, Tuongvan Nguyen, Jane Zulovich, et al.
Advanced Nanobiomed Research|August 26, 2021
An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma ModelAnshi Shukla, Juliana Cano-Mejia, Jaclyn Andricovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for NeuroblastomaRachel A Burga, Eric Yvon, Elizabeth Chorvinsky, et al.
ACS Nano|October 30, 2010
Biological nanofactories target and activate epithelial cell surfaces for modulating bacterial quorum sensing and interspecies signalingColin G Hebert, Apoorv Gupta, Rohan Fernandes, et al.
Metabolic Engineering|January 24, 2007
Magnetic nanofactories: localized synthesis and delivery of quorum-sensing signaling molecule autoinducer-2 to bacterial cell surfacesRohan Fernandes, Chen-Yu Tsao, Yoshifumi Hashimoto, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Visualized Experiments : Jove|May 21, 2015
Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applicationsJennifer M Vojtech, Juliana Cano-Mejia, Matthieu F Dumont, et al.
Nanomaterials (Basel, Switzerland)|August 12, 2022
Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for GlioblastomaNicole F Bonan, Debbie K Ledezma, Matthew A Tovar, et al.
Nanomedicine (London, England)|July 9, 2016
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapyRachel A Burga, Shabnum Patel, Catherine M Bollard, et al.
Translational Oncology|July 12, 2020
CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastomaJuliana Cano-Mejia, Anshi Shukla, Debbie K Ledezma, et al.
Biomaterials Science|February 22, 2019
Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastomaJuliana Cano-Mejia, Michelle L Bookstaver, Elizabeth E Sweeney, et al.
Cytotherapy|July 17, 2016
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cellsRachel A Burga, Tuongvan Nguyen, Jane Zulovich, et al.
Advanced Nanobiomed Research|August 26, 2021
An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma ModelAnshi Shukla, Juliana Cano-Mejia, Jaclyn Andricovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for NeuroblastomaRachel A Burga, Eric Yvon, Elizabeth Chorvinsky, et al.
ACS Nano|October 30, 2010
Biological nanofactories target and activate epithelial cell surfaces for modulating bacterial quorum sensing and interspecies signalingColin G Hebert, Apoorv Gupta, Rohan Fernandes, et al.
Metabolic Engineering|January 24, 2007
Magnetic nanofactories: localized synthesis and delivery of quorum-sensing signaling molecule autoinducer-2 to bacterial cell surfacesRohan Fernandes, Chen-Yu Tsao, Yoshifumi Hashimoto, et al.
Pageof 6